Inflazome raises $17m from Novartis Venture Fund and Fountain Healthcare Partners to develop treatments for chronic inflammatory diseases.
Viewing entries by
Arna Ionescu Stoll
The New Yorker's Jerome Groopman writes about new discoveries around inflammation.
Dr. Matt Cooper, Inflazome's CEO, interviewed about new scientific discoveries regarding inflammation.
Read about Prof. Luke O'Neill's promising research to stop inflammation.